1. Home
  2. PMCB vs HTOO Comparison

PMCB vs HTOO Comparison

Compare PMCB & HTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • HTOO
  • Stock Information
  • Founded
  • PMCB 1996
  • HTOO 2020
  • Country
  • PMCB United States
  • HTOO Ireland
  • Employees
  • PMCB N/A
  • HTOO N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • HTOO Natural Gas Distribution
  • Sector
  • PMCB Health Care
  • HTOO Utilities
  • Exchange
  • PMCB Nasdaq
  • HTOO Nasdaq
  • Market Cap
  • PMCB 15.8M
  • HTOO 12.3M
  • IPO Year
  • PMCB N/A
  • HTOO N/A
  • Fundamental
  • Price
  • PMCB $1.76
  • HTOO $0.56
  • Analyst Decision
  • PMCB
  • HTOO Buy
  • Analyst Count
  • PMCB 0
  • HTOO 2
  • Target Price
  • PMCB N/A
  • HTOO $3.25
  • AVG Volume (30 Days)
  • PMCB 36.5K
  • HTOO 152.3K
  • Earning Date
  • PMCB 09-17-2024
  • HTOO 12-02-2024
  • Dividend Yield
  • PMCB N/A
  • HTOO N/A
  • EPS Growth
  • PMCB N/A
  • HTOO N/A
  • EPS
  • PMCB 0.54
  • HTOO N/A
  • Revenue
  • PMCB N/A
  • HTOO $4,580,524.00
  • Revenue This Year
  • PMCB N/A
  • HTOO $440.97
  • Revenue Next Year
  • PMCB N/A
  • HTOO $214.20
  • P/E Ratio
  • PMCB $3.31
  • HTOO N/A
  • Revenue Growth
  • PMCB N/A
  • HTOO N/A
  • 52 Week Low
  • PMCB $1.39
  • HTOO $0.46
  • 52 Week High
  • PMCB $2.58
  • HTOO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 48.48
  • HTOO 48.06
  • Support Level
  • PMCB $1.72
  • HTOO $0.48
  • Resistance Level
  • PMCB $1.95
  • HTOO $0.56
  • Average True Range (ATR)
  • PMCB 0.26
  • HTOO 0.05
  • MACD
  • PMCB -0.01
  • HTOO 0.01
  • Stochastic Oscillator
  • PMCB 38.75
  • HTOO 75.00

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About HTOO Fusion Fuel Green PLC

Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.

Share on Social Networks: